Irruptive diseases require instant medical attention. The BioFire FilmArray System, alongside other multiplex PCR assays, enables quick, accurate results that detect multiple pathogens from one sample during several hours of testing. Rapid results through this method dramatically shorten the amount of time required to identify infections that include sepsis, respiratory diseases, and gastrointestinal issues.
The use of conventional diagnostic methods extends into multiple days, thus delaying treatment procedures and affecting patient health outcomes. Healthcare providers can deliver faster responses through multiplex PCR panels that enhance patient treatment outcomes together with accurate diagnostics.
Comprehensive Testing with Multiplex RT PCR Panels
“Multiplex RT PCR panels” represent a breakthrough in infectious disease diagnostics. Multiplex PCR panels contain capabilities to detect several pathogens at once during a single test run, especially when patients show signs of multiple medical conditions.
The testing process becomes simpler through multiplex PCR panels since these devices enable several pathogen analyses simultaneously. A respiratory infection case assessed by multiplex PCR detection reveals all influenza and RSV infections and various associated respiratory viruses by using a single test.
Jant Pharmacal Corporation dedicates itself to delivering advanced diagnostic solutions that include multiplex PCR systems to increase medical care quality and enhance clinical operational efficiency.
Enhanced Treatment Decisions
Patient treatment decisions become faster when clinical staff use multiplex PCR assays. Therapy targeting specific pathogens leads to optimum results while decreasing potential treatment complications.
Such screening practices lead to less use of broad-spectrum antibiotics while we fight antimicrobial resistance. BioFire FilmArray Panels prove effective in raising targeted therapy delivery by 41% thus enhancing clinicians’ ability to choose specific infection treatments.
Support for Antimicrobial Stewardship
The primary benefit of multiplex PCR testing is that it helps medical staff practice better antimicrobial stewardship. These assay systems generate swift, accurate findings, which help physicians prevent prescribing unneeded antibiotic medications.
Research demonstrates that the BioFire Respiratory Panel decreases antibiotic prescriptions when it determines whether a disease stems from a virus or bacterium. Patient outcomes receive improvement through accurate treatment administration when the testing occurs at the correct time while simultaneously lowering antibiotic resistance risks.
Cost-Effective Healthcare
Healthcare expenses benefit considerably from using multiplex PCR assays because of their reduced healthcare cost potential. By providing accurate diagnoses promptly, medical staff can avoid excessive testing, cut down patient hospitalization length, and minimize unnecessary treatment of wrong diseases.
The BioFire GI Panel has enabled healthcare facilities to save $293.61 per patient through decreased medical expenses from reduced procedures and tester repetitions. Multiplex PCR testing provides an advantageous solution to healthcare systems that need to balance cost management with improved patient results.
Improved Patient Outcomes
Time becomes crucial for managing infectious diseases. The accelerated diagnostic process of multiplex PCR technology leads to faster medical interventions, which results in enhanced patient care. Medical professionals equipped with this technology can reach exact diagnosis decisions that diminish treatment-related difficulties as well as invasive operations and mortality rates.
The complete and efficient detection method is revolutionizing infectious disease diagnosis while generating improved outcomes for medical teams and patients.
